7 results
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... the treatment of cancer-associated ... DVT = deep vein ... #Algorithm #Anticoagulation ... #Management #Hematology
Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease
 • Superficial Venous Thrombosis
 • Upper
Consensus 2019: Duration ... post-thrombotic syndrome ... Thrombophilia • Cancer ... #management #DVT ... #hematology #length
Approach to Thrombotic Microangiopathy (TMA) - Differential Diagnosis and Management Algorithm

Suspected TMA: Unexplained thrombocytopenia + MAHA
Diagnosis and Management ... Algorithm Suspected ... Direct antiglobulin test ... aPTT normal • DAT ... #Algorithm #hematology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
and incidental DVT ... or PE in cancer ... thrombosis in cancer ... without concomitant DVT ... #Management #Hematology
Heparin Induced Thrombocytopenia (HIT) - Diagnosis and Management - GrepMed Handbook

Presentation: 
 • Plts ↓50% (nadir
5-10d, venous (DVT ... approach for post-test ... : Confirmatory test ... , DOAC • A/C Duration ... #Treatment #Hematology
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Thromboembolism Treatment Algorithm ... Isolated distal DVT ... Unprovoked proximal DVT ... Thromboembolism #Treatment #Algorithm ... #management #hematology
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
MI, stroke, DVT/ ... • Treatment algorithms ... Thrombocythemia #ET #hematology ... #diagnosis #management ... #hematology